Bleomycin, Methotrexate and Vincristine Before Irradiation of Stage III and IV Laryngeal and Pharyngeal Squamous Cell Carcinoma: A Study Initiated by the Danish Society of Head and Neck Cancer Dahanca I

References

• Bertino J. R., Boston B., Capizzi B. L. The role of chemotherapy in the management of cancer of the head and neck. A review. Cancer 1975; 36: 752
   Google Scholar
• Clifford P. Prospectives in head and neck oncology. J. Laryng. 1976; 90: 221
   PubMed Web of Science ®Google Scholar
• Decker D. A., Drelichman A., Jacobs J., et al. Adjuvant chemotherapy with cis-diamminodichloro-platinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer 1983; 51: 1353
   PubMed Web of Science ®Google Scholar
• von Essen C. F., Joseph L. B. M., Simon G. T., Singh A. D., Singh S. P. Sequential chemotherapy and radiation therapy of buccal mucosa carcinoma in South India. Amer. J. Roentgenol. 1968; 102: 530
   Web of Science ®Google Scholar
• Fazekas J. T., Sommer C., Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx supraglottic larynx or hypopharynx. Int. J. Radiat. Oncol. Biol. Phys. 1980; 6: 533
   PubMed Web of Science ®Google Scholar
• Frei E. Prospectus for cancer chemotherapy. Cancer 1972; 30: 1656
   PubMed Web of Science ®Google Scholar
• Friedman M., Daly J. F. The treatment of squamous cell carcinoma of the head and neck with methotrexate and irradiation. Amer. J. Roentgenol. 1967; 99: 289
   Web of Science ®Google Scholar
• Hong W. K., Bromer R. Chemotherapy in head and neck cancer. New Engl. J. Med. 1983; 308: 175
   Web of Science ®Google Scholar
• Israel L., Depierre A., Chahinian P. Combination chemotherapy for 418 cases of advanced cancer. Cancer 1971; 27: 1089
   PubMed Web of Science ®Google Scholar
• Kish J., Drelichman A., Jacobs J., et al. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat. Rep. 1982; 66: 471
   PubMedGoogle Scholar
• Weaver A., Jacobs J., Cummings G., Al-Sarrof M. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 1984; 53: 1819
   PubMed Web of Science ®Google Scholar
• Kligerman M. M., Hellman S., von Essen C. F., Pertino J. R. Sequential chemotherapy and radiotherapy. Radiology 1966; 87: 247
   Google Scholar
• Laccourreye H., Brasnu D., Beuttir P., Chabolle F., Braquilanges E., de Strunski W. Résultats préliminaires d'une polychimiothérapie pré-opératoire dans les épithéliomas du pharyngo-larynx Oncovin, méthotrexate et bléomycin. Ann. Otolaryng. 1981; 98: 411
   Google Scholar
• Livingston R. B., Carter S. K. Single agents in cancer chemotherapy. IFI/Plenum, New York, NY 1970
   Google Scholar
• Marcial V. A., Velez-Garcia E., Figueroa-Valles N. R., Cintron J., Vallecillo L. A. Preliminary report of a pilot study of the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 1980; 6: 717
   PubMed Web of Science ®Google Scholar
• Molinari R., Mattavelli F., Cantu G., Chiesa F., Costa L., Tancini G. Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (V-B-M) based on cell kinetics in the palliative treatment of head and neck squamous cell carcinoma. Europ. J. Cancer 1980; 16: 469
   PubMed Web of Science ®Google Scholar
• Overgaard J., Andersen A. P., Jensen R. H., et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of the larynx and the pharynx. A preliminary report of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 2. Acta Otolaryngol. 1982, Suppl No 386: 215
   Google Scholar
• Pennacchio J. L., Hong W. K., Shapsay S., et al. Combination of cis-platinum and bleomycin prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced squamous carcinoma of the head and neck. Cancer 1982; 50: 2795
   PubMed Web of Science ®Google Scholar
• Price L. A., Hill B. T., Calvert A. H., Shaw H. J., Hughes K. B. Kinetically-based multiple drug treatment for advanced head and neck cancer. Brit. Med. J. 1975; 3: 10
   PubMedGoogle Scholar
• Richard J. M., Sancho A., Lepizhe Y., Rodary J., Pierquin B. Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx. Cancer 1974; 34: 491
   PubMed Web of Science ®Google Scholar
• Ruffmann R., Seifert R., Ross H., Haass H. C. Präoperativ-chemotherapeutische Behandlung bei Plattenepithelkarzinom im Kopf-Hals-Bereich mit dem V-B-M-Schema. Laryng. Rhinol. 1981; 60: 271
   PubMedGoogle Scholar
• Rygard J., Hansen H. S. Bleomycin as adjuvant in radiation therapy of advanced squamous cell carcinoma in head and neck. Acta Otolaryngol. 1979, Suppl. No. 360: 161
   PubMedGoogle Scholar
• Schuller D. E., Wilson H. E., Smith R. E., Batley F., James A. D. Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx and hypopharynx. Cancer 1983; 51: 15
   PubMed Web of Science ®Google Scholar
• Snow G. B. Intra-arterial infusion chemotherapy in head and neck cancer. A clinical and experimental study. Arch. Chir. Neerl. 1973; 25: 363
   PubMedGoogle Scholar
• Wasserman T. H., Slavik M., Carter S. K. Clinical comparison of the nitrosoureas. Cancer 1975; 36: 1258
   PubMed Web of Science ®Google Scholar
• Weaver A., Flemming S., Kish J., et al. Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer. Amer. J. Surg. 1982; 144: 445
   PubMed Web of Science ®Google Scholar